Copenhagen, Denmark

Henrik Nilsson

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • København, DK (2009)
  • København K, DK (2013)
  • Copenhagen, DK (2013 - 2014)

Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Henrik Nilsson in Bone Treatment

Introduction

Henrik Nilsson, an accomplished inventor based in Copenhagen, Denmark, has made significant strides in the field of medical treatments related to bone conditions. With a total of four patents to his name, his work focuses on innovative therapies utilizing strontium compounds that aim to improve patient outcomes in orthopedics.

Latest Patents

Among Henrik's latest inventions is a patented combination treatment that employs strontium for the prophylaxis and treatment of cartilage and bone conditions. This groundbreaking method involves administering a strontium-containing compound along with one or more active substances that help reduce the risk of bone fractures, increase bone density, enhance fracture healing, and improve the overall quality of bone.

In another significant patent, he introduced a treatment method for necrotic bone conditions. This method addresses osteonecrotic diseases in mammals, such as idiopathic or secondary osteonecrosis and glucocorticoid-induced bone ischemia. By administering an effective dose of a strontium-containing compound, this innovation demonstrates promise in treating these serious bone conditions.

Additionally, Henrik has developed a method for treating osteonecrotic bone diseases in patients undergoing therapies that may induce apoptosis or necrosis of bone cells. By combining a strontium-containing compound with a therapeutic agent, this approach aims to protect the bone cells from damage, showcasing Henrik’s commitment to advancing orthopedic treatments.

Career Highlights

Henrik Nilsson is currently associated with Osteologix A/S, where he contributes to pioneering efforts in bone health and treatment methodologies. His expertise in the application of strontium compounds has positioned him at the forefront of orthopedic research, enabling significant advancements in patient care.

Collaborations

Nilsson works alongside esteemed colleagues Christian Hansen and Stephan Christgau, who share a dedication to developing innovative solutions for bone-related ailments. Their collaboration fosters a creative environment that enhances the potential for breakthroughs in orthopedic therapies.

Conclusion

In conclusion, Henrik Nilsson's contributions to the field of bone treatment through his patents and collaborations have established him as a prominent figure in medical innovation. His work at Osteologix A/S continues to inspire advancements in the treatment of cartilage and bone conditions, signaling a positive direction for future research and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…